HF
RCEL icon

HRT Financial’s Avita Medical RCEL Stock Holding History

HRT Financial’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42K Buy
+10,179
New +$43.9K ﹤0.01% 3813
2025
Q4 		– Sell
-93,026
Closed -$475K – 3880
2025
Q3 		$475K Buy
+93,026
New +$485K ﹤0.01% 1928
2023
Q2 		– Sell
-11,522
Closed -$160K – 3125
2023
Q1 		$160K Buy
+11,522
New +$123K ﹤0.01% 1968
2022
Q2 		– Sell
-15,991
Closed -$135K – 3588
2022
Q1 		$135K Buy
+15,991
New +$147K ﹤0.01% 2591

Other funds holding RCEL

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial's RCEL Position: Q2 2026 in Review

HRT Financial opened a new position in Avita Medical (RCEL) in Q2 2026: 10,179 shares worth $42K. The stake represents ﹤0.01% of the portfolio and ranks #3813 among its holdings. This is a return to the name: HRT Financial previously reported a position in RCEL as recently as Q3 2025.

HRT Financial first reported a position in RCEL in Q1 2022 and has held it in 4 quarters since. The position peaked at $475K in Q3 2025. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • HRT Financial held 10,179 shares of Avita Medical worth $42K as of Q2 2026.
  • Avita Medical was a new HRT Financial position in Q2 2026.
  • Avita Medical made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3813 holding.
  • HRT Financial first reported a position in Avita Medical in Q1 2022 and has held it in 4 quarters since.
  • HRT Financial's Avita Medical position peaked at $475K in Q3 2025.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.